Stock Rating Downgrade
During the last several trading days the Value Trend Rating for Integra LifeSciences Holdings Co (NASDAQ: IART) weakened from C to D reflecting eroding fundamentals and low Appreciation Potential.
Recent Price Action
Integra LifeSciences Holdings Co (NASDAQ: IART) stock closed at $17.87 on 9/27/24 after a large increase of 2.3%. However, unusually low trading volume at 65% of normal accompanied the advance. The stock has been extremely weak relative to the market over the last nine months but has risen 2.3% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to exceed the cost of capital, IART is expected to continue to be an important Value Builder.
Integra LifeSciences Holdings has a current Value Trend Rating of D (Negative). The Value Trend Rating reflects very contradictory signals from PTR's two proprietary measures of a stock's attractiveness. Integra LifeSciences Holdings has a good Appreciation Score of 83 but a very low Power Rating of 2, resulting in the Negative Value Trend Rating.